The Allstate Corporation
NYSEAllstate heads into its October 28 earnings date with a notable divergence: the Street is actively debating the stock's valuation ceiling while corporate insiders have been selling in size. The insider picture is the most concrete signal this week. Over the past 90 days, net insider selling has reached roughly $23.8 million in open-market transactions — a material outflow for a…
ALL short interest falls to 1.9% of float, down 38% in one month as Argus downgrades to Hold from Buy.
Allstate heads into its October 28 earnings date with a notable divergence: the Street is actively debating the stock's valuation ceiling while corporate insiders have been selling in size. The insider picture is the…
Allstate has shed nearly a quarter of its short interest in the past week. Now a second analyst firm has piled on with a downgrade — even as the bears are leaving. Keefe, Bruyette & Woods downgraded ALL to Underperform…
Snapshot as of 20 Sept 2026
Allstate has seen its most dramatic short-interest unwind of the year in the nine days since Q2 results landed — but the analyst community that consensus note flagged as divided has only grown more fractured since. The…
Allstate reports Q2 results today with the hedging pressure that characterized the pre-earnings setup four days ago now fading — but the analyst divide it revealed has not. Options positioning has eased since the…
Allstate reports Q2 results on August 5 with the stock up 11% over the past month to $264.08 — yet options traders have quietly grown more defensive since the July 29 print. The clearest shift in positioning is in the…
Allstate reports second-quarter results on July 29 with short sellers pulling back and the stock trading near multi-month highs — setting up a debate about whether the recent re-rating has run ahead of the…
ALL enters the final two weeks before its July 29 earnings report with the Street divided — UBS just stepped to the sidelines while JP Morgan raised its target to a new high, and options traders are sitting at the most…
ALL heads into its July 29 earnings report with the stock up 14% in a month, analysts lifting targets across the board, and options traders showing the most defensive positioning of the past year. The options signal is…
Allstate heads into its Q1 2026 earnings print on Thursday with call-side positioning at its most dominant reading in over a year — and the stock up 4.2% on the week to $224.58, already pricing in some optimism before…
Allstate reports Q1 2026 results on May 22 with analysts tilting constructively, even as options traders have quietly shifted to their most bullish posture in months. The most striking signal heading into the print is…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ALL — free to start on ORTEX.
Sign up for free →Open ALL on ORTEX